Spatial transcriptomics exploration of the primary neuroblastoma microenvironment in archived <scp>FFPE</scp> samples unveils novel paracrine interactions
High-risk neuroblastomas exhibit a high degree of intratumoral heterogeneity. Single-cell RNA sequencing has greatly improved our understanding of these tumors, but the method lacks cellular tissue context and spatial information about local signaling dynamics. To address this, we profiled untreated and chemotherapy-treated high-risk neuroblastomas from archived, formalin-fixed, paraffin-embedded (FFPE) tissues from two patients using spatial transcriptomics. We confirmed the transcriptional and cellular heterogeneous nature of the neuroblastoma microenvironment and identified several unique spatial niches and patterns. In one of the treated tumors, a spatially constrained cluster of undifferentiated and 11p-gained cancer cells was identified, surrounded by a rim of macrophages. A signaling interaction between the chemokine CCL18 and its receptor PITPNM3 was predicted between these cells. In the other tumor, we identified a stromal cluster with high transcriptional similarity to the adrenal cortex. These adrenocortical-like cells expressed several oncogenic ligand-encoding genes (e.g. ALKAL2 and NRTN), which were predicted to communicate with neighboring cancer cells that expressed the corresponding receptors (e.g. ALK, RET). Several of these interactions were further validated experimentally and were shown to be clinically relevant. Collectively, our spatial analysis identifies multiple previously unrecognized signaling axes that may offer novel therapeutic options in neuroblastoma. © 2025 The Author(s). The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.
Authors
- Ruth H. Palmer (ORCID: https://orcid.org/0000-0002-2735-8470)
- Joachim T. Siaw (ORCID: https://orcid.org/0000-0002-1286-4485)
- Marcus Borenäs (ORCID: https://orcid.org/0009-0007-6326-5224)
- David Gisselsson (ORCID: https://orcid.org/0000-0002-0301-426X)
- Jimmy Van den Eynden (ORCID: https://orcid.org/0000-0003-0002-5614)
- Peter Merseburger (ORCID: https://orcid.org/0000-0002-5154-8696)
- A. Claeys (ORCID: https://orcid.org/0000-0001-6990-1569)
- Eva Jennische (ORCID: https://orcid.org/0000-0002-2147-8412)
- Dan E. Lind (ORCID: https://orcid.org/0000-0002-8299-5659)
- Caroline Jansson (ORCID: https://orcid.org/0009-0001-4115-0414)
- Jenny Karlsson (ORCID: https://orcid.org/0000-0001-7681-0059)
Institutions
- Lund University (SE)
- Ghent University Hospital (BE)
- Ghent University (BE)
- Cancer Research Institute Ghent (BE)
- University of Gothenburg (SE)
Publication Details
- Journal
- The Journal of Pathology
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1002/path.6457
- Citations
- 5
- Primary Topic
- Neuroblastoma Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 6.95
Funders
- Cancerfonden
- Fonds Wetenschappelijk Onderzoek
- Knut och Alice Wallenbergs Stiftelse
- Vetenskapsrådet
- Stiftelsen Assar Gabrielssons Fond
- Stichting Tegen Kanker
- Barncancerfonden
- Science for Life Laboratory
- Uppsala Multidisciplinary Center for Advanced Computational Science